Showing results (131-140 of 195) with videos related to
Sort By:
Pageof 20
Environmental Health Perspectives|March 13, 2008
Compound cytotoxicity profiling using quantitative high-throughput screeningMenghang Xia, Ruili Huang, Kristine L Witt, et al.Journal of Medicinal Chemistry|November 1, 2013
Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptorSamarjit Patnaik, Juan J Marugan, Ke Liu, et al.Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bryan T Mott, Cordelle Tanega, Min Shen, et al.Chemical Research in Toxicology|July 31, 2013
Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screeningMatias S Attene-Ramos, Ruili Huang, Srilatha Sakamuru, et al.Nature Reviews. Drug Discovery|December 15, 2019
Therapies for rare diseases: therapeutic modalities, progress and challenges aheadErik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, et al.Methods in Enzymology|November 18, 2006
Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate formatDouglas S Auld, Ronald L Johnson, Ya-qin Zhang, et al.European Journal of Human Genetics : EJHG|November 22, 2017
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impactHanns Lochmüller, Josep Torrent I Farnell, Yann Le Cam, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.Journal of Biomolecular Screening|June 8, 2014
Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug EfficacyDaozhan Yu, Manju Swaroop, Mengqiao Wang, et al.Science (New York, N.Y.)|August 6, 2011
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targetsJing Yuan, Ken Chih-Chien Cheng, Ronald L Johnson, et al.Pageof 20